We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In a recent survey of U.S. clinicians, 95 percent agreed that IV dislodgements pose significant safety risks for patients and hospitals, the company said. Read More
The biomarker software can help physicians direct patients into certain treatment courses or target enrollment for clinical trials, the company said. Read More
The new assay is the first in a series of planned quantitative assays to support patient care following transplant surgery, the company said. Read More
Diadem’s AlzoSure Predict blood-based biomarker test for early prediction of Alzheimer's disease (AD) can accurately forecast whether individuals will develop the disease six years prior to a diagnosis, according to research reported in the Journal of Prevention of Alzheimer's Disease. Read More
The device yields a greater quantity of diagnostically relevant biopsy tissue for diagnosis of pancreatic cancer and other life-threatening GI cancers more quickly and less traumatically than existing devices, the company said. Read More